Multiple myeloma patients to get NHS access to Amgen’s Kyprolis

14th June 2017 Uncategorised 0

The National Institute for Health and Care Excellence is backing routine NHS use of Amgen’s Kyprolis as an option for treating patients with multiple myeloma at first relapse.

More: Multiple myeloma patients to get NHS access to Amgen’s Kyprolis
Source: News